When semaglutide peaks after injection — and what that means for you

The hours after you inject: what's happening in your body

Picture the morning after your first Wegovy injection. You may not feel dramatically different, and that's expected. Semaglutide is absorbed gradually through the subcutaneous tissue, so the concentration in your bloodstream climbs slowly rather than spiking the way a fast-acting tablet might. Clinical pharmacokinetic data, referenced in the NHS medicines page for semaglutide, confirm that peak levels are typically reached somewhere between one and three days after the injection, with considerable individual variation based on body composition and injection depth.

This slow ascent is by design. GLP-1 receptor agonists work partly by slowing gastric emptying and signalling fullness to the brain, effects that benefit from a sustained, even exposure rather than a short burst. The medicine binds tightly to albumin (a protein that circulates in your blood), which acts like a molecular slow-release mechanism, preventing rapid clearance by the kidneys.

For most people, the practical upshot in week one is subtle: perhaps a modest reduction in appetite a day or two after injecting, possibly some mild nausea as the gut adjusts. The stronger appetite effects tend to build across subsequent weeks as the dose escalates and steady-state concentrations accumulate. If you're curious about what the first days feel like in practice, our page on how soon after injection semaglutide works covers the expected timeline in more detail.

Steady state: the point where weekly doses start stacking

A question our prescribers hear most weeks is some version of: "I'm on week three and still not noticing much, is that normal?" The answer almost always comes back to steady state. With a half-life of around seven days, each new dose lands before the previous week's drug has fully cleared. Over roughly four to five weekly injections, the troughs between doses rise until the peaks and troughs stabilise at a consistent level, this is steady state, and it's when Wegovy's appetite-suppressing effect typically becomes most noticeable.

Clinical trials reflected in NICE's appraisal of semaglutide (TA875) used dose-escalation schedules that run for several months before patients reach the maintenance dose, partly because the body's response is cumulative. Expecting full effect at week two is like expecting a plant to flower the day you water it. The pharmacology simply doesn't move that fast.

This is also why consistency matters. Missing a dose mid-titration doesn't just mean one skipped week, it introduces a dip in those steadily climbing trough levels. If you're unsure about the timing rules for your weekly injection, the guidance on when to take your semaglutide injection explains what to do if a dose is late or missed, though your prescriber and Patient Information Leaflet are always the final word on that.

Does where you inject change when the peak arrives?

Not in any clinically meaningful way. Absorption rates from the abdomen, thigh, and upper arm are broadly comparable for subcutaneous semaglutide, so rotating between sites (which is recommended to avoid skin changes at any one spot) won't noticeably shift when you hit peak concentration. What does vary slightly between sites is local tolerability: some people find the abdomen absorbs with less sting, others prefer the thigh. If injection comfort is something you're thinking about, it's worth reading up on the best injection site for Wegovy before you settle into a routine.

Temperature at the injection site can, in theory, influence absorption speed marginally (warmer tissue has greater blood flow) but this effect is small enough that it isn't a practical consideration for most people. What matters far more is technique: injecting into skin that's been pinched gently, at the right depth, and kept clean. Our page covering whether semaglutide stings when injected addresses some of the technique questions that come up around this.

For a broader grounding in the injection process itself, the overview of semaglutide injections covers the practical essentials. Understanding peak timing fits neatly into that bigger picture, knowing your medicine is building steadily, and that the first few weeks are pharmacological setup rather than failure, makes it easier to stay the course.

When timing context becomes a clinical conversation

The 24-to-72-hour peak window is a population average, not a personal guarantee. Individual factors (body weight, subcutaneous fat thickness, any other medicines being taken, kidney function) can nudge that curve earlier or later. Some people report their appetite suppression feeling strongest two days after each injection; others notice a consistent low point just before the next dose is due. Neither pattern is wrong. It's simply the pharmacokinetics playing out differently in different bodies.

If you're finding the effects uneven week to week, or if side effects seem timed oddly relative to your injection day, that's worth raising with your prescriber rather than adjusting your schedule unilaterally. The full guide to semaglutide injections sets out what's within normal variation and what warrants a clinical conversation. Understanding the science here is useful context; it doesn't replace the prescriber's assessment of how treatment is going for you specifically. To understand how Wegovy fits into the broader private treatment landscape, the Wegovy overview page is a good place to start, and if cost context matters to you, the Wegovy pricing page covers what a private prescription typically involves.

Treatment with semaglutide for weight management is available through a regulated private pharmacy following a clinical consultation. If you'd like to understand whether Wegovy might be appropriate for you, check your eligibility with our prescribers, the consultation is free, and a GPhC-registered clinician, not software, reviews every application.